The DOI matches its Crossref record.
Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered
Abstract
Paraffin sections or fine-needle aspiration smears from 5,993 cases of invasive mammary carcinomas were assessed immunohistochemically for estrogen receptor (ER; 1D5) and progesterone receptor (PR; 636) expression. Staining pattern and intensity were correlated with histologic subtypes and nuclear grades of tumors. Positive nuclear staining for ER and PR was observed in 75% and 55% of invasive carcinomas, respectively. In 92% of ER+ cases, diffuse and uniform staining of most tumor cells was observed. In the remaining 8%, a focal ER reaction was seen, usually because of inadequate fixation. In 21% of PR+ tumors, the reaction was heterogeneous or focal but unrelated to fixation. There were no ER-, PR+ tumors. All pure tubular, colloid, and infiltrating lobular carcinomas were ER+. All medullary, apocrine, and metaplastic and most high-nuclear-grade carcinomas were ER-. With monoclonal antibody 1D5 and antigen retrieval, immunohistochemical reaction for ER in breast cancer usually is an all-or-none phenomenon; therefore, quantitation of results is unnecessary. Despite antigen retrieval, inadequate fixation can cause false-negative results; evaluation of internal positive control samples is imperative. ER positivity and negativity are predictable in certain histologic types and nuclear grades of breast cancer. The reaction for PR can be heterogeneous or focal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Current issues in ER and HER2 testing by IHC in breast cancer
Gown, A. M. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.34 · Cited by 374
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast
Lester, S. C., Bose, S., Chen, Y.-Y., Connolly, J. L., de Baca, M. E., Fitzgibbons, P. L., Hayes, D. F., Kleer, C., O'Malley, F. P., Page, D. L., et al. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.10.1515 · Cited by 302
The Role of Progesterone Receptors in Breast Cancer
Li, Z., Wei, H., Li, S., Wu, P., & Mao, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s336643 · Cited by 264
Ohoka, N., Okuhira, K., Ito, M., Nagai, K., Shibata, N., Hattori, T., Ujikawa, O., Shimokawa, K., Sano, O., Koyama, R., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768853 · Cited by 240
“SNIPER(ER)-87 Inhibits Estrogen Signaling and Estrogen-dependent Tumor Growth—Because ER plays an essential role in estrogen signaling and the growth of certain ER -positive breast tumor cells (31, 32), we next examined the effect of SNIPER(ER)-87 on estrogen-dependent gene expression and tumor growth.”
Background
Metadata
- Authors
- Nadji, M., Gomez-Fernandez, C., Ganjei-Azar, P., & Morales, A. R.
- Venue
- American Journal of Clinical Pathology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 123
- Issue
- 1
- Pages
- 21-27
- ISSN
- 0002-9173 (ISSN-L)
- OpenAlex
- W1829077072
- Cited by
- 426
- References
- 0
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered. https://app.cochat.ai/papers/10.1309/4wv7-9n2g-hj3x-1841
- The paper
- Nadji, M., Gomez-Fernandez, C., Ganjei-Azar, P., & Morales, A. R. (2005). Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered. American Journal of Clinical Pathology. https://doi.org/10.1309/4wv7-9n2g-hj3x-1841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.